Suppr超能文献

亨廷顿舞蹈症中强直与舞蹈症的神经化学底物

Neurochemical substrates of rigidity and chorea in Huntington's disease.

作者信息

Storey E, Beal M F

机构信息

Neurochemistry Laboratory, Massachusetts General Hospital, Boston.

出版信息

Brain. 1993 Oct;116 ( Pt 5):1201-22. doi: 10.1093/brain/116.5.1201.

Abstract

Huntington's disease is a progressive degenerative neurological disorder which produces a characteristic movement disorder termed chorea. Although chorea is associated with dysfunction of the basal ganglia, the underlying mechanisms by which dyskinesias such as chorea are produced, are poorly understood. Recent studies in primates have led to experimental models of chorea with postulated involvement of specific neural pathways. In the present study we attempted to determine the validity of the experimental models by measuring concentrations of gamma-aminobutyric acid (GABA), glutamate, substance P and met-enkephalin in the basal ganglia of Huntington's disease patients who manifested either chorea or rigidity/bradykinesia within 6 months of death. We also characterized changes in the Huntington's disease patients according to pathological grade, since this may be a confounding factor. We analysed post-mortem brain tissue from 12 controls, and 11 grade 3 and 12 grade 4 Huntington's disease patients. The grade 3 and 4 cases consisted of eight adult-onset choreic, nine adult-onset rigid and six juvenile-onset rigid patients. We also analysed the putamen and globus pallidus from 11 grade 2 adult onset choreic Huntington's disease patients. A model of chorea based on experimental studies in primates proposes that a loss of striatal GABAergic inhibitory projections to the globus pallidus externa leads to increased activity of the inhibitory globus pallidus externa GABAergic neurons which project to the subthalamic nucleus. It is believed that the loss of GABAergic inputs to the globus pallidus externa precedes a loss of GABAergic input to the globus pallidus interna, which occurs later in the disease and is associated with the development of rigidity and bradykinesia. In the choreic Huntington's disease patients whom we studied, there was a greater loss of GABA in the globus pallidus externa than in the globus pallidus interna, and the globus pallidus interna: globus pallidus externa GABA ratio was significantly increased compared with rigid patients. There were also increases in GABA in the subthalamic nucleus in the choreic patients, although this did not reach significance. A differential loss of met-enkephalin in the globus pallidus externa compared with substance P loss in the globus pallidus interna was not observed in either the choreic patients with advanced disease or the grade II patients. There was a significant increase in GABA concentrations in the ventroanterior nucleus of the thalamus in the choreic patients compared with rigid/bradykinetic patients.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

亨廷顿舞蹈症是一种进行性退行性神经疾病,会导致一种名为舞蹈症的特征性运动障碍。尽管舞蹈症与基底神经节功能障碍有关,但舞蹈症等运动障碍产生的潜在机制仍知之甚少。最近对灵长类动物的研究已得出舞蹈症的实验模型,并推测特定神经通路参与其中。在本研究中,我们试图通过测量在死亡6个月内表现出舞蹈症或强直/运动迟缓的亨廷顿舞蹈症患者基底神经节中γ-氨基丁酸(GABA)、谷氨酸、P物质和甲硫氨酸脑啡肽的浓度,来确定这些实验模型的有效性。我们还根据病理分级对亨廷顿舞蹈症患者的变化进行了特征描述,因为这可能是一个混杂因素。我们分析了12名对照者以及11名3级和12名4级亨廷顿舞蹈症患者的死后脑组织。3级和4级病例包括8名成年发病的舞蹈症患者、9名成年发病的强直患者和6名青少年发病的强直患者。我们还分析了11名2级成年发病舞蹈症型亨廷顿舞蹈症患者的壳核和苍白球。基于对灵长类动物的实验研究建立的舞蹈症模型提出,纹状体向外侧苍白球的GABA能抑制性投射丧失会导致投射到丘脑底核的外侧苍白球GABA能抑制性神经元活性增加。据信,外侧苍白球GABA能输入的丧失先于内侧苍白球GABA能输入的丧失,内侧苍白球GABA能输入的丧失在疾病后期出现,并与强直和运动迟缓的发展有关。在我们研究的舞蹈症型亨廷顿舞蹈症患者中,外侧苍白球中GABA的丧失比内侧苍白球更严重,与强直患者相比,内侧苍白球与外侧苍白球的GABA比值显著增加。舞蹈症患者丘脑底核中的GABA也有所增加,但未达到显著水平。在晚期舞蹈症患者或2级患者中,均未观察到外侧苍白球中甲硫氨酸脑啡肽的丧失与内侧苍白球中P物质丧失的差异。与强直/运动迟缓患者相比,舞蹈症患者丘脑腹前核中的GABA浓度显著增加。(摘要截选至400字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验